Drug
Hgh Viaderm System
Hgh Viaderm System: highest development phase Phase 1, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| hGH-ViaDerm™ System (hGH or somatropin) NCT00455260 | Phase 1 | Growth Hormone Deficiency |
Latest
No recent events.
Follow Hgh Viaderm System on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.